Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

KALA

KALA BIO (KALA)

KALA BIO Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:KALA
DatumZeitQuelleÜberschriftSymbolFirma
08/01/202502h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
08/01/202502h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
08/01/202502h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
03/01/202513h07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KALAKALA BIO Inc
31/12/202422h13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:KALAKALA BIO Inc
30/12/202415h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
30/12/202414h00GlobeNewswire Inc.KALA BIO Announces $10,750,000 Private PlacementNASDAQ:KALAKALA BIO Inc
27/11/202414h00GlobeNewswire Inc.KALA BIO to Present at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
14/11/202422h49Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KALAKALA BIO Inc
12/11/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALAKALA BIO Inc
12/11/202414h00GlobeNewswire Inc.KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
25/09/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
06/09/202422h06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:KALAKALA BIO Inc
08/08/202414h00GlobeNewswire Inc.KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:KALAKALA BIO Inc
06/08/202414h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
06/08/202414h00GlobeNewswire Inc.KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
01/08/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KALAKALA BIO Inc
31/07/202422h08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KALAKALA BIO Inc
25/07/202422h10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KALAKALA BIO Inc
17/07/202423h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KALAKALA BIO Inc
16/07/202423h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KALAKALA BIO Inc
09/07/202402h54Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:KALAKALA BIO Inc
27/06/202414h00GlobeNewswire Inc.KALA BIO Announces $12,500,000 Private PlacementNASDAQ:KALAKALA BIO Inc
13/06/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
13/06/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
13/06/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
12/06/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
04/06/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
04/06/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
04/06/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
 Showing the most relevant articles for your search:NASDAQ:KALA

Kürzlich von Ihnen besucht

Delayed Upgrade Clock